在患有慢性脏疾病的患者中,加巴丁诱导的肌
Ammar N Mohamed1,2,3, Marie-Alex Michel4, Samy I McFarlane5
1Internal Medicine, State University of New York Downstate Medical Center University Hospital, Brooklyn, USA.
Cureus
|November 29, 2023
概括
用于和神经疼痛的加巴丁可以在患有脏问题的患者中引起严重的动. 剂量调整对于患有功能衰竭的人来说至关重要,以防止不良影响.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 腎臟病學 (nephrology) 是一種醫學專業.
背景情况:
- 加巴丁是一种GABA模拟剂,用于治疗和神经病痛.
- 它通过与α2δ (Ca) 通道子单元结合而起作用,调节神经递质释放.
- gabapentin 主要通过脏分泌,因此在功能障碍时需要调整剂量.
研究的目的:
- 突出加巴丁在功能不良患者中可能产生严重不良反应的潜力.
- 要强调在功能受损的患者中仔细加巴丁剂量定位的重要性.
主要方法:
- 这是一个病例报告,详细介绍了患者的临床表现和治疗.
- 该报告侧重于在先前患有慢性功能障碍的患者中加巴丁剂量升级后观察到的不良影响.
主要成果:
- 一名患有慢性功能障碍的患者在加巴丁剂量增加后出现了严重的肌动作.
- 这表明,由于脏分泌功能受损,加巴丁水平升高与神经不良事件之间存在潜在联系.
结论:
- 在患有功能不全的患者中,对 gabapentin 的剂量进行调整至关重要,以预防严重的不良事件.
- 临床医生在给患有脏疾病的患者处方 gabapentin 时应谨慎行事,并监测神经学副作用.
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
186
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
186
Antiepileptic Drugs: Glutamate Antagonists
376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
Antiepileptic Drugs: GABAergic Pathway Potentiators
414
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
414
Renal Failure: Dose Adjustments
95
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
95
Skeletal Muscle Relaxants: Adverse Effects
375
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
375
Antiepileptic Drugs: Calcium Channel Blockers
414
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
414


